[Effect of piracetam on inorganic phosphates and phospholipids in the blood of patients with cerebral infarction in the earliest period of the disease].
The influence of piracetam on the level of inorganic and phospholipid phosphorus in blood of ischemic stroke patients was evaluated. In healthy patients piracetam (2G, i.v.) diminished the concentration of inorganic phosphorus and essentially lowered the content of ion connected with phospholipids. In stroke patients inorganic phosphorus was primarily enhanced and organic lowered. Treatment with piracetam lowered the concentration of both inorganic and phospholipid phosphorus in blood.
Kawiak
W
W
Katedry i Kliniki Neurologii Akademii Medycznej, Lublinie.
Pilarczyk
M
M
Chmielewska
B
B
Gieracz-Nazar
A
A
D000208:Acute Disease; D000367:Age Factors; D000368:Aged; D002544:Cerebral Infarction / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D010710:Phosphates / Q000037:antagonists & inhibitors / Q000097:blood*; D010743:Phospholipids / Q000037:antagonists & inhibitors / Q000097:blood*; D010889:Piracetam / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D010710:Phosphates; D010743:Phospholipids; D010889:Piracetam
Wpływ piracetamu na zachowanie sie fosforu nieorganicznego i fosforu zwiazanego z lipidami we krwi chorych z zawałem mózgu w najwcześniejszym okresie choroby.